A share price of Staar Surgical Co [STAA] is currently trading at $24.98, up 2.97%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The STAA shares have lost -1.61% over the last week, with a monthly amount drifted -4.44%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Staar Surgical Co [NASDAQ: STAA] stock has seen the most recent analyst activity on July 15, 2024, when Morgan Stanley downgraded its rating to a Underweight and also revised its price target to $37 from $50. Previously, BTIG Research upgraded its rating to Buy on June 11, 2024, and kept the price target unchanged to $46. On March 11, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $50 on the stock. Needham downgraded its rating to a Hold. Morgan Stanley initiated its recommendation with a Equal-Weight and recommended $35 as its price target on December 04, 2023. The Benchmark Company downgraded its rating to Hold for this stock on September 15, 2023. In a note dated August 03, 2023, Canaccord Genuity downgraded an Hold rating on this stock and revised its target price from $77 to $48.
Staar Surgical Co experienced fluctuations in its stock price throughout the past year between $23.72 and $52.68. Currently, Wall Street analysts expect the stock to reach $54.58 within the next 12 months. Staar Surgical Co [NASDAQ: STAA] shares were valued at $24.98 at the most recent close of the market. An investor can expect a potential return of 118.49% based on the average STAA price forecast.
Analyzing the STAA fundamentals
Trailing Twelve Months sales for Staar Surgical Co [NASDAQ:STAA] were 341.22M which represents 10.31% growth. Gross Profit Margin for this corporation currently stands at 0.79% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at 0.1%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.05 and Total Capital is 0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 24.20 points at the first support level, and at 23.42 for the second support level. However, for the 1st resistance point, the stock is sitting at 25.49, and for the 2nd resistance point, it is at 26.00.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Staar Surgical Co [NASDAQ:STAA] is 5.99. As well, the Quick Ratio is 5.38, while the Cash Ratio is 2.47. Considering the valuation of this stock, the price to sales ratio is 3.61, the price to book ratio is 2.87 and price to earnings (TTM) ratio is 57.02.
Transactions by insiders
Recent insider trading involved BROADWOOD PARTNERS, L.P., 10% Owner, that happened on Dec 16 ’24 when 53500.0 shares were purchased. 10% Owner, BROADWOOD PARTNERS, L.P. completed a deal on Dec 18 ’24 to buy 23000.0 shares. Meanwhile, 10% Owner BROADWOOD PARTNERS, L.P. bought 3700.0 shares on Dec 17 ’24.
